Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 68 | 3,149 | N/A | N/A |
| TOTAL | $103 | $3,242 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 26 | 26 | N/A | N/A |
| Other Non-Current Assets | 3 | 3 | 0 | 0 |
| TOTAL | $29 | $29 | $N/A | $N/A |
| Total Assets | $132 | $3,271 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 935 | 116 | 0 | 0 |
| Other current liabilities | 443 | 85 | N/A | N/A |
| TOTAL | $1,378 | $201 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,378 | $201 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -10,762 | -6,446 | N/A | N/A |
| Other shareholders' equity | 9,348 | 9,348 | 0 | 0 |
| TOTAL | $-1,246 | $3,070 | $N/A | $N/A |
| Total Liabilities And Equity | $132 | $3,271 | $0 | $0 |